<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The role of endothelin in the pathogenesis of <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> after subarachinoid <z:mp ids='MP_0001914'>hemorrhage</z:mp> was investigated by evaluating the effect of FR139317, a novel potent <z:chebi fb="209" ids="16000,53460">ETA</z:chebi> receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi>, on the vasospasm in a canine two-<z:mp ids='MP_0001914'>hemorrhage</z:mp> model </plain></SENT>
<SENT sid="1" pm="."><plain>Intracisternal administration of FR139317 (0.1 mg) significantly reduced the vasoconstriction of the basilar artery at day 7 (control group, n = 6, 61.6 +/- 4.0%, FR139317 treated group, n = 6, 75.9 +/- 1.5% of basal diameter, p &lt; 0.01) </plain></SENT>
<SENT sid="2" pm="."><plain>In <z:mpath ids='MPATH_458'>normal</z:mpath> anesthetized dogs, the intracisternal administration of FR139317 did not affect the basal diameter of the basilar artery, blood pressure or heart rate </plain></SENT>
<SENT sid="3" pm="."><plain>These results suggest that endothelin plays an important role in the pathogenesis of <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> after <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo>, and that FR139317 could be a valuable tool for preventing vasospasm after <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> </plain></SENT>
</text></document>